Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

537 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Using qPCR and ddPCR to study biodistribution of cell therapy products: a multi-site evaluation.
Fujita E, Yamamoto S, Hanada T, Jogasaki S, Koga Y, Yatsuda Y, Kakizaki Y, Jo Y, Asano Y, Yonezawa K, Moriya Y, Nakayama M, Arimura Y, Okawa Y, Komatsu H, Ito M, Suzuki S, Kuroda T, Yasuda S, Kamiyama Y, Sato Y. Fujita E, et al. Among authors: moriya y. Cytotherapy. 2024 Oct 5:S1465-3249(24)00864-8. doi: 10.1016/j.jcyt.2024.09.003. Online ahead of print. Cytotherapy. 2024. PMID: 39453335 Free article.
Non-clinical, quality and environmental impact assessments of cell and gene therapy products: Report on the 5th Asia Partnership Conference of Regenerative Medicine - April 7, 2022.
Tanaka T, Karasawa H, Yasumoto M, Choi BH, Chang R, Komuro M, Miyano M, Moriya Y, Muthusamy S, Okubo S, Takakura K, Tsurumaki Y, Watanabe T, Wen K, Yoneda T, Yuan TT, Nomura M. Tanaka T, et al. Among authors: moriya y. Cytotherapy. 2023 Jul;25(7):683-698. doi: 10.1016/j.jcyt.2023.03.012. Epub 2023 Apr 24. Cytotherapy. 2023. PMID: 37097265 Free article. Review.
Regulatory insights on advanced CAR-T cell products, AAV-based Gene therapies, and medical care/practice in cell and Gene therapies: Report from the 6th Asia partnership conference of regenerative medicine- April 20, 2023.
Karasawa H, Mizoguchi H, Choi B, Hsieh CL, Miyano M, Moriya Y, Muthusamy S, Takakura K, Suzuki K, Tsurumaki Y, Watanabe T, Wen K, Yoneda T, Yuan TT, Nomura M. Karasawa H, et al. Among authors: moriya y. Regen Ther. 2024 Oct 29;26:967-980. doi: 10.1016/j.reth.2024.09.015. eCollection 2024 Jun. Regen Ther. 2024. PMID: 39524180 Free PMC article. Review.
Highlights of the 15th Japan Bioanalysis Forum Symposium.
Niwa M, Arakawa T, Arai K, Koyama N, Hara H, Hata K, Hashimoto M, Shimada E, Shimizu H, Takamatsu Y, Uchiyama H, Yamaguchi T, Yamamoto K, Kakehi M, Moriya Y, Kurisu H, Nagaya H, Nakazawa T, Noguchi S, Oda Y, Okamoto H, Uchihashi S. Niwa M, et al. Among authors: moriya y. Bioanalysis. 2024;16(19-20):1005-1010. doi: 10.1080/17576180.2024.2395715. Epub 2024 Sep 12. Bioanalysis. 2024. PMID: 39263699
jPOST environment accelerates the reuse and reanalysis of public proteome mass spectrometry data.
Okuda S, Yoshizawa AC, Kobayashi D, Takahashi Y, Watanabe Y, Moriya Y, Hatano A, Takami T, Matsumoto M, Araki N, Tabata T, Iwasaki M, Sugiyama N, Kodera Y, Tanaka S, Goto S, Kawano S, Ishihama Y. Okuda S, et al. Among authors: moriya y. Nucleic Acids Res. 2024 Nov 11:gkae1032. doi: 10.1093/nar/gkae1032. Online ahead of print. Nucleic Acids Res. 2024. PMID: 39526391
Autism spectrum disorder-like behaviors induced by hyper-glutamatergic NMDA receptor signaling through hypo-serotonergic 5-HT1A receptor signaling in the prefrontal cortex in mice exposed to prenatal valproic acid.
Kurahashi H, Kunisawa K, Tanaka KF, Kubota H, Hasegawa M, Miyachi M, Moriya Y, Hasegawa Y, Nagai T, Saito K, Nabeshima T, Mouri A. Kurahashi H, et al. Among authors: moriya y. Neuropsychopharmacology. 2024 Oct 11. doi: 10.1038/s41386-024-02004-z. Online ahead of print. Neuropsychopharmacology. 2024. PMID: 39394255
Effect of the thyroid transcription factor 1 expression and treatment discontinuation due to adverse events on progression-free survival in patients with advanced non-squamous non-small cell lung cancer treated with pembrolizumab plus pemetrexed and platinum chemotherapy: a Japanese four-hospital, retrospective study.
Mori S, Maiguma T, Yoshii K, Moriya Y, Takada R, Shinkai F, Haruki Y, Hashimoto H, Komoto A, Takayanagi K, Tamura K, Okura Y, Sugiyama T, Shimada K. Mori S, et al. Among authors: moriya y. Am J Cancer Res. 2024 Aug 25;14(8):3852-3858. doi: 10.62347/JTWP3747. eCollection 2024. Am J Cancer Res. 2024. PMID: 39267683 Free PMC article.
537 results